PERIPHERAL NERVE PARESIS

PERIPHERAL NERVE PARESIS was reported 45 times

PERIPHERAL NERVE PARESIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 CD52-directed Cytolytic Antibody [EPC] 2 0.0001
1 Thrombopoietin Receptor Agonist [EPC] 1 0.0001
2 Aldosterone Antagonist [EPC] 4 0.0000
3 Hepatitis C Virus NS5A Inhibitor [EPC] 1 0.0000
4 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 2 0.0000
5 CTLA-4-directed Blocking Antibody [EPC] 1 0.0000
6 Ester Local Anesthetic [EPC] 1 0.0000
7 Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] 1 0.0000
8 Factor Xa Inhibitor [EPC] 5 0.0000
9 Mood Stabilizer [EPC] 3 0.0000
10 Anti-epileptic Agent [EPC] 3 0.0000
11 Topoisomerase Inhibitor [EPC] 1 0.0000
12 Non-Standardized Chemical Allergen [EPC] 1 0.0000
13 CD20-directed Cytolytic Antibody [EPC] 4 0.0000
14 Nucleoside Analog Antiviral [EPC] 1 0.0000
15 Amide Local Anesthetic [EPC] 1 0.0000
16 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
17 Antiarrhythmic [EPC] 1 0.0000
18 Interleukin-12 Antagonist [EPC] 1 0.0000
19 Interleukin-23 Antagonist [EPC] 1 0.0000
20 Folate Analog Metabolic Inhibitor [EPC] 4 0.0000
21 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
22 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
23 Calcineurin Inhibitor Immunosuppressant [EPC] 1 0.0000
24 Benzodiazepine [EPC] 5 0.0000
25 Leukocyte Growth Factor [EPC] 1 0.0000
26 Corticosteroid [EPC] 9 0.0000
27 Progestin [EPC] 2 0.0000
28 Azole Antifungal [EPC] 1 0.0000
29 Dihydropyridine Calcium Channel Blocker [EPC] 2 0.0000
30 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
31 HMG-CoA Reductase Inhibitor [EPC] 2 0.0000
32 Alkylating Drug [EPC] 1 0.0000
33 Platelet Aggregation Inhibitor [EPC] 2 0.0000
34 beta-Adrenergic Blocker [EPC] 1 0.0000
35 Nonsteroidal Anti-inflammatory Drug [EPC] 3 0.0000
36 Insulin Analog [EPC] 1 0.0000